Module

Viral Pathogenesis: HIV Persistence and Resistance in Latent Reservoirs

Source: HIV/AIDS Annual Update 2006

Viral Pathogenesis: HIV Persistence and Resistance in Latent Reservoirs


CME Program Director: John P. Phair, MD

Faculty:

  • Robert F. Siliciano, MD, PhD

CME CREDIT INFORMATION

Release Date: 06/30/06

Expiration Date: 06/29/07


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the significance of HIV reservoirs for the persistence of HIV infection
  • Identify the mechanisms underlying viral persistence in the setting of HAART
  • Explain the importance of viral blips in patients receiving suppressive antiretroviral therapy and their association with persistent immune activation

Topics covered include:

  • Introduction
  • Formation of a Stable Viral Reservoir
  • Archiving of Viral Strains
  • Residual Viremia and Viral Blips
  • Conclusions
  • Summary—Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.